Christopher Galletta - Dec 13, 2024 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role
Controller and Principal Accounting Officer
Signature
/s/ Christopher Galletta
Stock symbol
TRVI
Transactions as of
Dec 13, 2024
Transactions value $
$7,665
Form type
4
Date filed
12/17/2024, 04:30 PM
Previous filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRVI Common Stock Options Exercise $7.67K +15K +303.95% $0.51 19.9K Dec 13, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRVI Stock Option (right to buy) Options Exercise $0 -15K -42.86% $0.00 20K Dec 13, 2024 Common Stock 15K $0.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,935 shares purchased through the Issuer's employee stock purchase plan.
F2 This option was granted on February 11, 2022. The 35,000 shares of common stock underlying the option vested as to 25% of the shares on February 11, 2023 and vest as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.

Remarks:

Controller and Principal Accounting Officer